Article info

Download PDFPDF
L6 Evaluation of pridopidine in the transgenic yac128 mouse model of huntington’s disease

Authors

  • Marta Garcia Miralles 1Translational Laboratory in Genetic Medicine, Singapore PubMed articlesGoogle scholar articles
  • Liang Juin Tan 1Translational Laboratory in Genetic Medicine, Singapore PubMed articlesGoogle scholar articles
  • Madeline Lim 1Translational Laboratory in Genetic Medicine, Singapore PubMed articlesGoogle scholar articles
  • Michal Geva 2Research and Development, Teva Pharmaceuticals Netanya, Israel PubMed articlesGoogle scholar articles
  • Michael R Hayden 1Translational Laboratory in Genetic Medicine, Singapore 2Research and Development, Teva Pharmaceuticals Netanya, Israel 3Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore PubMed articlesGoogle scholar articles
  • Mahmoud A Pouladi 1Translational Laboratory in Genetic Medicine, Singapore 3Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore PubMed articlesGoogle scholar articles

Citation

Miralles MG, Tan LJ, Lim M, et al
L6 Evaluation of pridopidine in the transgenic yac128 mouse model of huntington’s disease

Publication history

  • First published September 13, 2016.
Online issue publication 
September 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.